Siddharth Banka

Siddharth Banka

Auto-generated profile, based on publicly available information

Siddharth Banka

Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ASAlejandro Sifrim
Alejandro Sifrim
MHMarc-Phillip Hitz
Marc-Phillip Hitz
AWAnna Wilsdon
Anna Wilsdon
JBJeroen Breckpot
Jeroen Breckpot
STSaeed H Al Turki
Saeed H Al Turki
MHMatthew E Hurles
Matthew E Hurles
Matthew Hurles and colleagues report exome sequencing of 1,891 individuals with syndromic or nonsyndromic congenital heart defects (CHD). They found that nonsyndromic CHD patients were enriched for protein-truncating variants in CHD-associated genes inherited from unaffected parents and identified three new syndromic CHD disorders caused by de novo mutations. Congenital heart defects (CHDs) have a neonatal incidence of 0.8–1% (refs. 1,2). Despite abundant examples of monogenic CHD in humans and mice, CHD has a low absolute sibling recurrence risk (∼2.7%)3, suggesting a considerable role for de novo mutations (DNMs) and/or incomplete penetrance4,5. De novo protein-truncating variants (PTVs) have been shown to be enriched among the 10% of 'syndromic' patients with extra-cardiac manifestations6,7. We exome sequenced 1,891 probands, including both syndromic CHD (S-CHD, n = 610) and nonsyndromic CHD (NS-CHD, n = 1,281). In S-CHD, we confirmed a significant enrichment of de novo PTVs but not inherited PTVs in known CHD-associated genes, consistent with recent findings8. Conversely, in NS-CHD we observed significant enrichment of PTVs inherited from unaffected parents in CHD-associated genes. We identified three genome-wide significant S-CHD disorders caused by DNMs in CHD4, CDK13 and PRKD1. Our study finds evidence for distinct genetic architectures underlying the low sibling recurrence risk in S-CHD and NS-CHD.

1 January 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
VFVíctor Faundes
Víctor Faundes
WNWilliam Newman
William Newman
LBLaura Bernardini
Laura Bernardini
NCNatalie Canham
Natalie Canham
JCJill Clayton-Smith
Jill Clayton-Smith
MHMatthew E. . Hurles
Matthew E. . Hurles

1 June 2015 in Immunity
Verified
Journal Article
Closed access
BOBergithe E. Oftedal
Bergithe E. Oftedal
AHAlexander Hellesen
Alexander Hellesen
MEMartina M. Erichsen
Martina M. Erichsen
EBEirik Bratland
Eirik Bratland
AVAyelet Vardi
Ayelet Vardi
EHEystein S. Husebye
Eystein S. Husebye

4 December 2018 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
MAMargaret P Adam
Margaret P Adam
SBSiddharth Banka
Siddharth Banka
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
OBOlaf Bodamer
Olaf Bodamer
ACAlbert E Chudley
Albert E Chudley
NNNorio Niikawa
Norio Niikawa
Background: Kabuki syndrome (KS) is a clinically recognisable syndrome in which 70% of patients have a pathogenic variant in KMT2D or KDM6A. Understanding the function of these genes opens the door to targeted therapies. The purpose of this report is to propose diagnostic criteria for KS, particularly when molecular genetic testing is equivocal. Methods: An international group of experts created consensus diagnostic criteria for KS. Systematic PubMed searches returned 70 peer-reviewed publications in which at least one individual with molecularly confirmed KS was reported. The clinical features of individuals with known mutations were reviewed. Results: The authors propose that a definitive diagnosis can be made in an individual of any age with a history of infantile hypotonia, developmental delay and/or intellectual disability, and one or both of the following major criteria: (1) a pathogenic or likely pathogenic variant in KMT2D or KDM6A; and (2) typical dysmorphic features (defined below) at some point of life. Typical dysmorphic features include long palpebral fissures with eversion of the lateral third of the lower eyelid and two or more of the following: (1) arched and broad eyebrows with the lateral third displaying notching or sparseness; (2) short columella with depressed nasal tip; (3) large, prominent or cupped ears; and (4) persistent fingertip pads. Further criteria for a probable and possible diagnosis, including a table of suggestive clinical features, are presented. Conclusion: As targeted therapies for KS are being developed, it is important to be able to make the correct diagnosis, either with or without molecular genetic confirmation.

20 May 2022 in Science Advances
Verified
Journal Article
Open access
RJRanjay Jayadev
Ranjay Jayadev
MMMychel R. P. T. Morais
Mychel R. P. T. Morais
JEJamie Ellingford
Jamie Ellingford
SSSandhya Srinivasan
Sandhya Srinivasan
RNRichard W. Naylor
Richard W. Naylor
RLRachel Lennon
Rachel Lennon
Basement membranes (BMs) are ubiquitous extracellular matrices whose composition remains elusive, limiting our understanding of BM regulation and function. By developing a bioinformatic and in vivo discovery pipeline, we define a network of 222 human proteins and their animal orthologs localized to BMs. Network analysis and screening in C. elegans and zebrafish uncovered BM regulators, including ADAMTS, ROBO, and TGFβ. More than 100 BM network genes associate with human phenotypes, and by screening 63,039 genomes from families with rare disorders, we found loss-of-function variants in LAMA5 , MPZL2 , and MATN2 and show that they regulate BM composition and function. This cross-disciplinary study establishes the immense complexity of BMs and their impact on in human health.

10 June 2011 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MHMark C. Hannibal
Mark C. Hannibal
KBKati J. Buckingham
Kati J. Buckingham
SNSarah B. Ng
Sarah B. Ng
JMJeffrey E. Ming
Jeffrey E. Ming
ABAnita E. Beck
Anita E. Beck
MBMichael J. Bamshad
Michael J. Bamshad